The Expression implication of GDNF in ventral horn and associated remote cortex in rhesus monkeys with hemisected spinal cord injury

Document Type: Original Article

Authors

Laboratory of Anesthesia and Critical Care Medicine, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China

Abstract

Objective(s): Glial cell line-derived neurotrophic factor (GDNF) can effectively promote axonal regeneration,limit axonal retraction,and produce a statistically significant improvement in motor recovery after spinal cord injury (SCI). However, the role in primate animals with SCI is not fully cognized.
Materials and Methods:18 healthy juvenile rhesuses were divided randomly into six groups, observed during the periods of 24 hr, 7 days, 14 days, 1 month, 2 months, and 3 months after T11 hemisecting. The GDNF localization, changes in the injured region, and the remote associate cortex were detected by immunohistochemical staining.
Results: Immunohistochemical staining showed that GDNF was located in the cytoplasm and the neurite of the neurons. Following SCI, the number of GDNF positive neurons in the ventral horn and the caudal part near the lesion area were apparently reduced at detected time points (P<0.05). Moreover, the number in the rostral part of the ventral horn in 7 day, 14 day, and 1 month groups were fewer than those in the caudal part. Importantly, in the contralateral cortex motor area, the positive neurons decreased sharply after hemi-SCI, while gradually increased and went back to normal in 3 months after hemi-SCI.
Conclusion: To sum up, GDNF disruption in neurons occurred after SCI especially in cortex motor area. Intrinsic GDNF in the spinal cord, plays an essential role in neuroplasticity. Thereafter extrinsic GDNF supplementing may be a useful strategy to promote recovery after SCI.

Keywords


1.Calabro RS, Naro A, Leo A, Bramanti P. Usefulness of robotic gait training plus neuromodulation in chronic spinal cord injury: A case report. J Spinal Cord Med. 2016;1-4.

2.Bermingham N, Hillermann R, Gilmour F, Martin JE, Fisher EM. Human glial cell line-derived neurotrophic factor (gdnf) maps to chromosome 5. Hum Genet. 1995; 96:671-673.

3.Alvarez P, Chen X, Bogen O, Green PG, Levine JD. Ib4(+) nociceptors mediate persistent muscle pain induced by gdnf. J Neurophysiol. 2012; 108:2545-2553.

4.Satake K, Matsuyama Y, Kamiya M, Kawakami H, Iwata H, Adachi K, et al. Up-regulation of glial cell line-derived neurotrophic factor (gdnf) following traumatic spinal cord injury. Neuroreport. 2000; 11:3877-3881.

5.Cao L, Liu L, Chen ZY, Wang LM, Ye JL, Qiu HY, et al. Olfactory ensheathing cells genetically modified to secrete gdnf to promote spinal cord repair. Brain 2004; 127:535-549.

6.Tian W, Han XG, Liu YJ, Tang GQ, Liu B, Wang YQ, et al. Intrathecal epigallocatechin gallate treatment improves functional recovery after spinal cord injury by upregulating the expression of bdnf and gdnf. Neurochem Res 2013; 38:772-779.

7.Singh LP, Devi TS, Nantwi KD. Theophylline regulates inflammatory and neurotrophic factor signals in functional recovery after c2-hemisection in adult rats. Exp Neurol 2012; 238:79-88.

8.Abdanipour A, Schluesener HJ, Tiraihi T. Effects of valproic acid, a histone deacetylase inhibitor, on improvement of locomotor function in rat spinal cord injury based on epigenetic science. Iran Biomed J 2012;16:90-100.

9.Lv L, Han X, Sun Y, Wang X, Dong Q. Valproic acid improves locomotion in vivo after sci and axonal growth of neurons in vitro. Exp Neurol 2012; 233:783-790.

10.Han X, Yang N, Xu Y, Zhu J, Chen Z, Liu Z, et al. Simvastatin treatment improves functional recovery after experimental spinal cord injury by upregulating the expression of bdnf and gdnf. Neurosci Lett 2011; 487:255-259.

11.Fujiyoshi T, Kubo T, Chan CC, Koda M, Okawa A, Takahashi K, et al. Interferon-gamma decreases chondroitin sulfate proteoglycan expression and enhances hindlimb function after spinal cord injury in mice. J Neurotrauma 2010;27:2283-2294.

12.Tai PA, Chang CK, Niu KC, Lin MT, Chiu WT, Lin CM. Attenuating experimental spinal cord injury by hyperbaric oxygen: Stimulating production of vasculoendothelial and glial cell line-derived neurotrophic growth factors and interleukin-10. J Neurotrauma 2010; 27:1121-1127.

13.Deng LX, Hu J, Liu N, Wang X, Smith GM, Wen X, et al. Gdnf modifies reactive astrogliosis allowing robust axonal regeneration through schwann cell-seeded guidance channels after spinal cord injury. Exp Neurol. 2011;229:238-250.

14.Eggers R, de Winter F, Hoyng SA, Roet KC, Ehlert EM, Malessy MJ, et al. Lentiviral vector-mediated gradients of gdnf in the injured peripheral nerve: Effects on nerve coil formation, schwann cell maturation and myelination. PLoS One 2013;8:e71076.

15.Fontana X, Hristova M, Da Costa C, Patodia S, Thei L, Makwana M, et al. C-jun in schwann cells promotes axonal regeneration and motoneuron survival via paracrine signaling. J Cell Biol 2012;198:127-141.

16.Macias MY, Syring MB, Pizzi MA, Crowe MJ, Alexanian AR, Kurpad SN. Pain with no gain: Allodynia following neural stem cell transplantation in spinal cord injury. Exp Neurol 2006;201:335-348.

17.Ohta K, Inokuchi T, Gen E, Chang J. Ultrastructural study of anterograde transport of glial cell line-derived neurotrophic factor from dorsal root ganglion neurons of rats towards the nerve terminal. Cells Tissues Organs 2001;169:410-421.

18.Lonka-Nevalaita L, Lume M, Leppanen S, Jokitalo E, Peranen J, Saarma M. Characterization of the intracellular localization, processing, and secretion of two glial cell line-derived neurotrophic factor splice isoforms. J Neurosci 2010; 30:11403-11413.

19.Miyazaki H, Nagashima K, Okuma Y, Nomura Y. Expression of glial cell line-derived neurotrophic factor induced by transient forebrain ischemia in rats. Brain Res 2001;922:165-172.

20.Tokumine J, Sugahara K, Kakinohana O, Marsala M. The spinal gdnf level is increased after transient spinal cord ischemia in the rat. Acta Neurochir Suppl 2003;86:231-234.

21.Hammang JP, Emerich DF, Winn SR, Lee A, Lindner MD, Gentile FT, et al. Delivery of neurotrophic factors to the cns using encapsulated cells: Developing treatments for neurodegenerative diseases. Cell Transplant 1995; 4 Suppl 1:S27-28.

22.Sedel F, Bechade C, Triller A. Nerve growth factor (ngf) induces motoneuron apoptosis in rat embryonic spinal cord in vitro. Eur J Neurosci 1999;11:3904-3912.

23.Junger H, Varon S. Neurotrophin-4 (nt-4) and glial cell line-derived neurotrophic factor (gdnf) promote the survival of corticospinal motor neurons of neonatal rats in vitro. Brain Res 1997; 762:56-60.

24.Luquin MR, Manrique M, Guillen J, Arbizu J, Ordonez C, Marcilla I. Enhanced gdnf expression in dopaminergic cells of monkeys grafted with carotid body cell aggregates. Brain Res 2011; 1375:120-127.

25.Liu Y, Wang S, Luo S, Li Z, Liang F, Zhu Y, et al. Intravenous pep-1-gdnf is protective after focal cerebral ischemia in rats. Neurosci Lett 2016; 617:150-155.

26.Santos D, Giudetti G, Micera S, Navarro X, Del Valle J. Focal release of neurotrophic factors by biodegradable microspheres enhance motor and sensory axonal regeneration in vitro and in vivo. Brain Res 2016;1636:93-106.

27.Sharma HS. Selected combination of neurotrophins potentiate neuroprotection and functional recovery following spinal cord injury in the rat. Acta Neurochir Suppl 2010; 106:295-300.

28.Han Q, Xiang J, Zhang Y, Qiao H, Shen Y, Zhang C. Enhanced neuroprotection and improved motor function inettraumatized rat spinal cords by raav2-mediated glial-derived neurotrophic factor combined with early rehabilitation training. Chin Med J (Engl) 2014; 127:4220-4225.

29.Mandadi S, Leduc-Pessah H, Hong P, Ejdrygiewicz J, Sharples SA, Trang T, et al. Modulatory and plastic effects of kinins on spinal cord networks. J Physiol 2016;594:1017-1036.

30.Horinouchi K, Ikeda S, Harada K, Ohwatashi A, Kamikawa Y, Yoshida A, et al. Functional recovery and expression of gdnf seen in photochemically induced cerebral infarction. Int J Neurosci 2007;117:315-326.